Skip to Main Content

Paper Details

Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.
Pharmacogenet Genomics
0
2021
-, 46 SNPs, E1, E2, M3 genome, MA.27, PATIENTS, Single-nucleotide polymorphism, anastrozole, early breast cancer, estradiol, estrogen, estrone, patients, postmenopausal, single-nucleotide polymorphism, women

Datasets

Release 1.2